Good epidemic responses require cross-disciplinary collaboration. Dr David Heymann talks about serving in an Ebola containment campaign and Dr Christy Rentmeester explains what clinicians should know about colonialism to promote health equity.
How should we prepare for rapid advancement of gene editing technology? This month on Ethics Talk, Dr Sean C. McConnell provides an introduction to gene editing and CRISPR technology and Scott J. Schweikart discusses what prudent governance requires.
In reconstructive transplantation, quality of life assessments incorporate many variables. Dr Katrina Bramstedt and Dr Ana Iltis discuss the development of QoL assessment tools to help patient-subjects considering reconstructive transplantation.
In this episode, transgender advocate and author Ryan Sallans discusses his experience accessing health care as a transman and offers a guide for caring well for anyone with a cervix.
Implantable brain-computer interface (BCI) and other devices with potential for both therapeutic purposes and human enhancement are being rapidly developed. The distinction between therapeutic and enhancement uses of these devices is not well defined. While the US Food and Drug…
Many devices in current use were marketed before the US Food and Drug Administration (FDA) began regulating devices in 1976. Thus, manufacturers of these devices were not required to demonstrate safety and effectiveness, which presents both clinical and ethical problem…
Recent research has highlighted device representatives’ roles in surgical cases. Additional review of cases based on actual events suggests that lack of training on the part of a surgeon and surgical team and lack of knowledge and training on the…
The number of new medical devices cleared by the US Food and Drug Administration (FDA) through the 510(k) pathway that has subsequently been associated with safety risks has led to discussion of approaches to regulation and communication of device risks….
This article examines the history of device oversight by the US Food and Drug Administration (FDA). Significant regulatory changes occurred in response to injuries caused by Dalkon Shield intrauterine devices. This article summarizes those changes as well as continued efforts…
Medical school education must better align with patient care needs for a rapidly changing population. One challenge is to eliminate bias in merit-based admissions to more equitably review candidates with the structural competency skills desperately needed to promote public health…
© 2026
American Board of Medical Specialties | Policies | Sitemap | Terms of Use | www.abms.org
